Cover Image
Market Research Report - 244968

Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Published by GlobalData
Published Content info 105 Pages
Price
Back to Top
Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Published: June 18, 2012 Content info: 105 Pages
Description

Summary

GlobalData's new report, "Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global infectious immunology market. The report provides market landscape, competitive landscape and market trends information on the infectious immunology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Brazil and Australia.
  • Key segments covered include Hepatitis Viruses, Retroviruses, Bacteriology and Other Virology.
  • Annualized market revenues data from 2004 to 2011 and forecast forward for seven years to 2018. Company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints within infectious immunology market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Qiagen and Gen-Probe Incorporated.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the infectious immunology market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the infectious immunology market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global infectious immunology market and the factors shaping it.
Table of Contents

Table of contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Infectious Immunology Overview

  • 3.1. Infectious Immunology: Market Characterization
    • 3.1.1. Bacteriology
    • 3.1.2. Hepatitis Viruses
    • 3.1.3. Other Virology
    • 3.1.4. Retroviruses

4. Infectious Immunology-Global Market Characterization

  • 4.1. Infectious Immunology Market, Global, Revenue ($m), Historic, 2004-2011
  • 4.2. Infectious Immunology Market, Global, Revenue ($m), Forecast, 2011-2018
  • 4.3. Infectious Immunology Market, Key Trends
    • 4.3.1. New Technological Developments to Change the Infectious Immunology Market Landscape
    • 4.3.2. Use of Companion Diagnostics to Provide a Personalized Healthcare Solution for Infectious Disease Treatment can be a Key Focus Area in Future
    • 4.3.3. Growing Trend of Development of POCT Tests for Infectious Immunology due to Benefits such as Low Cost and Faster Results
  • 4.4. Global Infectious Immunology, Market Dynamics
    • 4.4.1. Market Drivers
    • 4.4.2. Market Restraints

5. Global Infectious Immunology Market: Analysis by Segment

  • 5.1. Bacteriology Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.2. Bacteriology Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.3. Bacteriology, Market Dynamics
    • 5.3.1. Market Drivers
    • 5.3.2. Market Restraint
  • 5.4. Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.5. Hepatitis viruses diagnostics Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.6. Hepatitis Viruses Diagnostics, Market Dynamics
    • 5.6.1. Market Drivers
    • 5.6.2. Market Restraint
  • 5.7. Other Virology Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.8. Other Virology Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.9. Other Virology, Market Dynamics
    • 5.9.1. Market Drivers
    • 5.9.2. Market Restraint
  • 5.10. Retroviruses Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.11. Retroviruses Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.12. Retroviruses, Market Dynamics
    • 5.12.1. Market Driver
    • 5.12.2. Market Restraint

6. Infectious Immunology Market, Analysis by Country, Revenue ($m), 2004-2018

  • 6.1. Infectious Immunology Market, the US, Revenue ($m), Historic, 2004-2011
  • 6.2. Infectious Immunology Market, the US, Revenue ($m), Forecast, 2011-2018
  • 6.3. Infectious Immunology Market, Canada, Revenue ($m), Historic, 2004. -2011
  • 6.4. Infectious Immunology Market, Canada, Revenue ($m), Forecast, 2011-2018
  • 6.5. Infectious Immunology Market, the UK, Revenue ($m), Historic, 2004-2011
  • 6.6. Infectious Immunology Market, the UK, Revenue ($m), Forecast, 2011-2018
  • 6.7. Infectious Immunology Market, Germany, Revenue ($m), Historic, 2004-2011
  • 6.8. Infectious Immunology Market, Germany, Revenue ($m), Forecast, 2011-2018
  • 6.9. Infectious Immunology Market, France, Revenue ($m), Historic, 2004-2011
  • 6.10. Infectious Immunology Market, France, Revenue ($m), Forecast, 2011-2018
  • 6.11. Infectious Immunology Market, Italy, Revenue ($m), Historic, 2004-2011
  • 6.12. Infectious Immunology Market, Italy, Revenue ($m), Forecast, 2011-2018
  • 6.13. Infectious Immunology Market, Spain, Revenue ($m), Historic, 2004-2011
  • 6.14. Infectious Immunology Market, Spain, Revenue ($m), Forecast, 2011-2018
  • 6.15. Infectious Immunology Market, Japan, Revenue ($m), Historic, 2004-2011
  • 6.16. Infectious Immunology Market, Japan, Revenue ($m), Forecast, 2011-2018
  • 6.17. Infectious Immunology Market, China, Revenue ($m), Historic, 2004-2011
  • 6.18. Infectious Immunology Market, China, Revenue ($m), Forecast, 2011-2018
  • 6.19. Infectious Immunology Market, India, Revenue ($m), Historic, 2004-2011
  • 6.20. Infectious Immunology Market, India, Revenue ($m), Forecast, 2011-2018
  • 6.21. Infectious Immunology Market, Australia, Revenue ($m), Historic, 2004-2011
  • 6.22. Infectious Immunology Market, Australia, Revenue ($m), Forecast, 2011-2018
  • 6.23. Infectious Immunology Market, Brazil, Revenue ($m), Historic, 2004-2011
  • 6.24. Infectious Immunology Market, Brazil, Revenue ($m), Forecast, 2011-2018

7. Infectious Immunology Market-Strategic Competitive Assessment

  • 7.1. Infectious Immunology, Market Share Assessment for Others
  • 7.2. Infectious Immunology, Key Market Participants
    • 7.2.1. Abbott Laboratories
    • 7.2.2. F. Hoffmann-La Roche Ltd.
    • 7.2.3. Siemens Healthcare

8. Infectious Immunology-Strategic Pipeline Assessment

9. Infectious Immunology Market-Strategic Deals Analysis

  • 9.1. Infectious Immunology Market, Partnerships, 2010-2012*
  • 9.2. Infectious Immunology Market, Venture Financing Deals, 2010-2012*
  • 9.3. Infectious Immunology Market, Asset Transaction Deals, 2010-2012*
  • 9.4. Infectious Immunology Market, Equity Offering Deals, 2010-2012*
  • 9.5. Infectious Immunology Market, Acquisitions, 2010-2012*
  • 9.6. Infectious Immunology Market, Debt Offering Deals, 2010-2012*
  • 9.7. Infectious Immunology Market, Private Equity Deals, 2010-2012*
  • 9.8. Infectious Immunology Market, Mergers, 2010-2012*
  • 9.9. Infectious Immunology Market, Licensing Agreement, 2010-2012*
  • 9.10. Key Deals
    • 9.10.1. Siemens Healthcare Diagnostics and Illumina Entered into a Collaboration Partnership
    • 9.10.2. Xcyton Announces Receipt of $4.5m from Fidelity Capital Advisors to Launch Novel Diagnostic Platform 'SES' for Critical Infections
    • 9.10.3. Abbott Enters into Co-Development Agreement with Genetics Lab for Molecular Assay Development
    • 9.10.4. Quanterix, Beth Israel Deaconess and Forsyth Institute Enter into Partnership to Develop a Tuberculosis Test

10. Appendix

  • 10.1. Market Definitions
    • 10.1.1. Infectious Immunology
  • 10.2. Acronyms
  • 10.3. Sources
  • 10.4. Research Methodology
    • 10.4.1. Secondary Research
    • 10.4.2. Primary Research
    • 10.4.3. Models
    • 10.4.4. Forecasts
    • 10.4.5. Expert Panels
  • 10.5. GlobalData Consulting
  • 10.6. Contact Us
  • 10.7. Disclaimer

List of Tables

  • Table 1: List of Viruses which Commonly Infect Humans, by Nucleic Acid and Family*
  • Table 2: Infectious Immunology Market, Global, Revenue ($m), 2004 - 2011
  • Table 3: Infectious Immunology Market, Global, Revenue ($m), 2011 - 2018
  • Table 4: Home Based Testing Market, by Application and Test Type
  • Table 5: Number of Corporate Diagnostic Laboratory Chains, India, 2010
  • Table 6: Bacteriology Market, Global, Revenue ($m), 2004 - 2011
  • Table 7: Bacteriology Market, Global, Revenue ($m), 2011 - 2018
  • Table 8: Bacteriology Market CAGR Comparison, by Country, 2004-2011
  • Table 9: Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), 2004 - 2011
  • Table 10: Hepatitis viruses diagnostics Market, Global, Revenue ($m), 2011 - 2018
  • Table 11: Other Virology Market, Global, Revenue ($m), 2004 - 2011
  • Table 12: Other Virology Market, Global, Revenue ($m), 2011 - 2018
  • Table 13: Retroviruses Market, Global, Revenue ($m), 2004 - 2011
  • Table 14: Retroviruses Market, Global, Revenue ($m), 2011 - 2018
  • Table 15: Number of New HIV Infection Cases, the US, 2006-2009
  • Table 16: Infectious Immunology Market, the US, Revenue ($m), 2004 - 2011
  • Table 17: Infectious Immunology Market, the US, Revenue ($m), 2011 - 2018
  • Table 18: Infectious Immunology Market, Canada, Revenue ($m), 2004-2011
  • Table 19: Infectious Immunology Market, Canada, Revenue ($m), 2011 - 2018
  • Table 20: Infectious Immunology Market, the UK, Revenue ($m), 2004-2011
  • Table 21: Infectious Immunology Market, the UK, Revenue ($m), 2011 - 2018
  • Table 22: Infectious Immunology Market, Germany, Revenue ($m), 2004 - 2011
  • Table 23: Infectious Immunology Market, Germany, Revenue ($m), 2011-2018
  • Table 24: Infectious Immunology Market, France, Revenue ($m), 2004-2011
  • Table 25: Infectious Immunology Market, France, Revenue ($m), 2011-2018
  • Table 26: Infectious Immunology Market, Italy, Revenue ($m), 2004-2011
  • Table 27: Infectious Immunology Market, Italy, Revenue ($m), 2011-2018
  • Table 28: Infectious Immunology Market, Spain, Revenue ($), 2004-2011
  • Table 29: Infectious Immunology Market, Spain, Revenue ($m), 2011-2018
  • Table 30: Infectious Immunology Market, Japan, Revenue ($m), 2004-2011
  • Table 31: Infectious Immunology Market, Japan, Revenue ($m), 2011-2018
  • Table 32: Infectious Immunology Market, China, Revenue ($m), 2004-2011
  • Table 33: Infectious Immunology Market, China, Revenue ($m), 2011-2018
  • Table 34: Infectious Immunology Market, India, Revenue ($m), 2004-2011
  • Table 35: Infectious Immunology Market, India, Revenue ($m), 2011-2018
  • Table 36: Infectious Immunology Market, Australia, Revenue ($m), 2004-2011
  • Table 37: Infectious Immunology Market, Australia, Revenue ($m), 2011-2018
  • Table 38: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011
  • Table 39: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018
  • Table 40: Infectious Immunology Market, Global, Company Share (%), 2011
  • Table 41: Abbott Laboratories, Key Marketed Products*, 2011
  • Table 42: F. Hoffmann-La Roche Ltd., Key Marketed Products*, 2011
  • Table 43: Roche, Infectious Disease Companion Diagnostics Tests, 2011
  • Table 44: Siemens Healthcare, Key Marketed Products*, 2011
  • Table 45: Siemens Healthcare, Emerging Markets Growth, 2008-2010
  • Table 46: Infectious Immunology, Global Pipeline Products, 2011
  • Table 47: Infectious Immunology, Global Pipeline Distribution, by Market Segments, 2011
  • Table 48: Infectious Immunology Market, Deals, 2010-2012*
  • Table 49: Infectious Immunology Market, Partnerships, 2010-2012*
  • Table 50: Infectious Immunology Market, Venture Financing Deals, 2010-2012*
  • Table 51: Infectious Immunology Market, Asset Transaction Deals, 2010-2012*
  • Table 52: Infectious Immunology Market, Equity Offering Deals, 2010-2012*
  • Table 53: Infectious Immunology Market, Acquisitions, 2010-2012*
  • Table 54: Infectious Immunology Market, Debt Offering Deals, 2010-2012*
  • Table 55: Infectious Immunology Market, Private Equity Deals, 2010-2012*
  • Table 56: Infectious Immunology Market, Mergers, 2010-2012*
  • Table 57: Infectious Immunology Market, Licensing Agreement, 2010-2012*

List of Figures

  • Figure 1: Infectious Immunology, Market Segmentation
  • Figure 2: Infectious Immunology Market, Global, Revenue ($m), 2004 - 2011
  • Figure 3: Infectious Immunology Market, Global, Revenue ($m), 2011 - 2018
  • Figure 4: Global Infectious Immunology, Market Dynamics
  • Figure 5: Hub and Spoke Model used by Diagnostic Laboratories
  • Figure 6: Innovation Funnel, Biomarker-based Molecular Diagnostic Product
  • Figure 7: Bacteriology Market, Global, Revenue ($m), 2004 - 2011
  • Figure 8: Bacteriology Market, Global, Revenue ($m), 2011 - 2018
  • Figure 9: Bacteriology Market CAGR Comparison, by Country, 2004-2011
  • Figure 10: Bacteriology Market, Developed* vs. Developing** Countries, Revenue Contribution (%)
  • Figure 11: Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), 2004 - 2011
  • Figure 12: Hepatitis viruses diagnostics Market, Global, Revenue ($m), 2011 - 2018
  • Figure 13: Hepatitis Testing Market Comparison, Developed* vs. Developing** Markets, 2011
  • Figure 14: Estimated New Cases for Hepatitis, the US, 2004-2009
  • Figure 15: Other Virology Market, Global, Revenue ($m), 2004 - 2011
  • Figure 16: Other Virology Market, Global, Revenue ($m), 2011 - 2018
  • Figure 17: Retroviruses Market, Global, Revenue ($m), 2004 - 2011
  • Figure 18: Retroviruses Market, Global, Revenue ($m), 2011 - 2018
  • Figure 19: Number of New HIV Infection Cases, the US, 2006-2009
  • Figure 20: Infectious Immunology Market, the US, Revenue ($m), 2004 - 2011
  • Figure 21: Infectious Immunology Market, the US, Revenue ($m), 2011 - 2018
  • Figure 22: Infectious Immunology Market, Canada, Revenue ($m), 2004 - 2011
  • Figure 23: Infectious Immunology Market, Canada, Revenue ($m), 2011 - 2018
  • Figure 24: Infectious Immunology Market, the UK, Revenue ($m), 2004 - 2011
  • Figure 25: Infectious Immunology Market, the UK, Revenue ($m), 2011 - 2018
  • Figure 26: Infectious Immunology Market, Germany, Revenue ($m), 2004 - 2011
  • Figure 27: Infectious Immunology Market, Germany, Revenue ($m), 2011-2018
  • Figure 28: Infectious Immunology Market, France, Revenue ($m), 2004-2011
  • Figure 29: Infectious Immunology Market, France, Revenue ($m), 2011-2018
  • Figure 30: Infectious Immunology Market, Italy, Revenue ($m), 2004-2011
  • Figure 31: Infectious Immunology Market, Italy, Revenue ($m), 2011-2018
  • Figure 32: Infectious Immunology Market, Spain, Revenue ($m), 2004-2011
  • Figure 33: Infectious Immunology Market, Spain, Revenue ($m), 2011-2018
  • Figure 34: Infectious Immunology Market, Japan, Revenue ($m), 2004-2011
  • Figure 35: Infectious Immunology Market, Japan, Revenue ($m), 2011-2018
  • Figure 36: Infectious Immunology Market, China, Revenue ($m), 2004-2011
  • Figure 37: Infectious Immunology Market, China, Revenue ($m), 2011-2018
  • Figure 38: Infectious Immunology Market, India, Revenue ($m), 2004-2011
  • Figure 39: Infectious Immunology Market, India, Revenue ($m), 2011-2018
  • Figure 40: Infectious Immunology Market, Australia, Revenue ($m), 2004-2011
  • Figure 41: Infectious Immunology Market, Australia, Revenue ($m), 2011-2018
  • Figure 42: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011
  • Figure 43: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018
  • Figure 44: Infectious Immunology Market, Global, Company Shares (%), 2011
  • Figure 45: Infectious Immunology, Market Share Assessment for Others
  • Figure 46: Abbott Laboratories, SWOT Analysis
  • Figure 47: F. Hoffmann-La Roche Ltd., SWOT Analysis
  • Figure 48: Roche, Revenue Distribution by Geography, 2011
  • Figure 49: Siemens Healthcare, SWOT Analysis
  • Figure 50: Siemens Healthcare, Revenue Share, by Region, 2010
  • Figure 51: Siemens Healthcare, Emerging Markets Growth, 2008-2010
  • Figure 52: Infectious Immunology, Global Pipeline Products, 2011
  • Figure 53: Infectious Immunology, Global Pipeline Distribution, by Market Segment, 2011
  • Figure 54: Infectious Immunology Market, Deals, 2010-2012*
Back to Top